{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-25-000082","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.535614+00:00","generated_at":"2026-05-17T00:41:06.197087+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nautilus regains Nasdaq minimum bid price compliance; deficiency closed","bullets":["Received notice on Nov 3, 2025 that closing bid price met $1 for 10 consecutive days.","Deficiency previously disclosed May 2, 2025; compliance period extended to April 27, 2026.","Company transferred to Nasdaq Capital Market on Oct 29, 2025 to utilize second compliance period.","Matter now closed; no further action required."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-25-000082","json":"https://secwatch.observer/filing/0001808805-25-000082.json","markdown":"https://secwatch.observer/filing/0001808805-25-000082.md","text":"https://secwatch.observer/filing/0001808805-25-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/0001808805-25-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/naut-20251103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:41:06.197087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}